~~<i id='9F93A44018'><strike id='9F93A44018'><tt id='9F93A44018'><pre id='9F93A44018'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

knowledge

fashion

author：explore 2025-10-01 15:39:25 - browse：33

Monica Bertagnolli -- health policy coverage from STAT — NIH Director Monica Bertagnolli Kevin Dietsch/Getty Images

WASHINGTON — President Biden has promised to require fair prices from drugmakers that use federally funded research — and now, in a major recent move, said he’ll trigger government “march-in” on patents for drugs that run afoul of that goal.

“It’s a simple principle. You shouldn’t pay the highest price in the world for drugs that your tax dollars have already helped create,” Biden said last month as he touted the move at the National Institutes of Health.

But the new NIH director, locked in the center of this debate, isn’t taking any big steps yet.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Hepatitis C has a cure — but many Americans still lack access to it
Next article： Grail spinoff by Illumina should end disastrous merger attempt

knowledge

leisure time

hotspot

focus

Wikipedia

focus

JEFFPACHOUD/AFPviaGettyImagesReducingoreliminatingalcoholconsumptionreducestheriskofdevelopingoralca

WSS

Prime Medicine, Myeloid Therapeutics clash over genome

Drinking less cuts risk of oral cavity, esophageal cancer: Report

Carvykti CAR

Keeping primary care docs in field isn't impossible, says AAFP CEO

Violet CEO on training clinicians to promote more inclusive care

Majority of Americans think Trump's Ga. election interference case is serious: POLL

knowledge

fashion

knowledge

Activists slam private health insurers over coverage restrictions

FDA approves first treatment for ultra

Moonlake's readout produced a cash windfall. Risks remain

Hospitals owned by private equity see complications spike 25%

Hollywood unions extend contract negotiations for actors

What STAT readers think about the FDA and patient advocacy

How one medical school became remarkably diverse

The pain doctors face in trying to build their families

DIEP, the 'gold standard' of breast reconstruction, is under threat

SNAP should offer more nutrition education

leisure time

Editas, Vertex strike deal on CRISPR

Living with Hashimoto's and celiac disease, and med school, too

Prime Medicine, Myeloid Therapeutics clash over genome

The pain doctors face in trying to build their families

Living with Hashimoto's and celiac disease, and med school, too

Prime Medicine, Myeloid Therapeutics clash over genome

hotspot

focus

Wikipedia

focus